|
|
On March
31 the State of Connecticut Stem Cell Research
Advisory Committee directed an additional $9.8 million
in stem cell research funds, the third installment of
grants from a Stem Cell Research Fund pledged to
provide $100 million in funding over 10 years. Click here for official press
release.
The awards came just one week after StemCONN 09, an
international symposium, brought scientists from
around Connecticut, the United States, and the world
to New Haven to discuss the latest stem cell research
findings.
"Bioscience is a driver of Connecticut’s current
economy, and stem cell research is a driver of
Connecticut’s current bioscience," said Paul
Pescatello, president and CEO of CURE, in a press
release issued at the symposium.
"The State’s
decision to make a proactive commitment to stem cell
research is proving to have been very wise indeed,"
Pescatello said. Click here for CURE press
release.
More than 630 registrants attended the two-day
symposium. A scientific poster session on the second
day attracted more than 70 posters.
Other popular
sessions included panels on bioethics and the
translation of stem cell research into clinical
therapies, as well as a general session on Connecticut’s
progress and scientific programs supported and
developed by Applied Biosystems, CellDesign, and
United Kingdom Science and Innovation.
The scientific
presentations on the second day were introduced by
Robert J. Alpern, M.D., Dean of the Yale School of
Medicine, and Cato Laurencin, M.D., Ph.D., Dean of the
University of Connecticut School of Medicine.
(The audio of the Translation to Clinic Workshop was
recorded and is available for download here as two MP3
files:
1:
Presentation (7.8mb)
2:
Q&A (5.6mb)
Media coverage included online blogs as well as
broadcasts on WQUN and WNPR and articles in the
Connecticut dailies. (Click for
WQUN (MP3), WNPR:
Ray Hardman, WNPR:
Where We Live, New
Haven Register, The
Day
(New London), RepublicanAmerican.
|
